Parenteral Nutrition Market Size & Growth Forecast 2026–2035, By Segments (Stage Type, Sales Channel, Nutrient Type, Indication), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Parenteral Nutrition Market size was around USD 7.89 Billion in 2025 and is slated to grow at a 6.1% CAGR from 2026 to 2035, crossing USD 14.26 Billion by 2035. The industry revenue for 2026 is estimated at USD 8.3 billion.
Get more details on this report
Request Free Sample ReportParenteral Nutrition Market Intelligence Snapshot
Regional Market Dynamics
- North America accounted for a 43.99% market share in 2025, supported by established hospital infrastructure, standardized clinical nutrition practices, and routine use across intensive and specialized care settings.
- Asia Pacific is expected to expand at a 6.89% CAGR, driven by improving hospital capacity, wider access to critical care, and growing adoption of clinical nutrition therapies across larger patient populations.
Segment Momentum
- Adults accounted for 82.75% of the market in 2025 due to widespread use of parenteral nutrition in hospital care for patients requiring nutritional support during major illness, surgery, or cancer treatment.
- Online sales are growing fastest because digital procurement improves purchasing convenience, repeat ordering, and product access, particularly as home-based care and outpatient nutrition management become more organized.
Market Expansion Drivers
- Rising cancer prevalence and gastrointestinal disorders increasing demand for intravenous nutritional support.
- Expanding home parenteral nutrition adoption and advanced multi-chamber formulations improving patient outcomes.
- Increasing premature birth rates accelerating neonatal and pediatric parenteral nutrition utilization.
Leading Market Participants
Global Market Forecast Snapshot
Market Outlook
Prominent players in the parenteral nutrition market include Baxter International Inc. (United States), Fresenius Kabi AG (Germany), B. Braun SE (B. Braun Melsungen AG) (Germany), Otsuka Pharmaceutical Factory, Inc. (Japan), Grifols, S.A. (Spain), Pfizer Inc. (United States), ICU Medical, Inc. (United States), Sichuan Kelun Pharmaceutical Co., Ltd. (China), JW Pharmaceutical Corporation (South Korea), CSL Limited (Australia).Regional and Segment Outlook
North AmericaMarket Growth Drivers and Industry Trends
As cancer incidence and gastrointestinal disorders rise, clinicians are encountering more patients who cannot maintain adequate oral or enteral intake because of tumor burden, treatment-related mucositis, bowel obstruction, malabsorption, short bowel syndrome, or severe inflammatory disease. This is driving demand for the parenteral nutrition market by making intravenous nutritional support a necessary part of care rather than an optional adjunct, particularly in oncology centers, intensive care settings, and specialized gastroenterology practice. The effect is visible in hospital purchasing patterns and treatment protocols, where providers increasingly rely on tailored amino acid, lipid, electrolyte, and micronutrient formulations to stabilize patients during prolonged treatment cycles and recovery periods, reinforcing market demand for both standardized and customized parenteral nutrition products.
Expanding home parenteral nutrition adoption and advanced multi-chamber formulations improving patient outcomes
A larger share of clinically stable patients is being managed outside acute care settings, and that shift is aiding market expansion for the parenteral nutrition market through stronger demand for home-compatible products, infusion systems, and monitoring services. Advanced multi-chamber formulations make this transition more practical by simplifying preparation, reducing compounding steps, improving storage and handling convenience, and helping lower contamination risk, which matters for long-term use in the home setting. As physicians and payers seek to reduce hospitalization burden while maintaining nutritional continuity for patients with chronic intestinal failure and related conditions, these formulations are influencing market adoption by aligning clinical safety, caregiver usability, and outpatient care models.
Increasing premature birth rates accelerating neonatal and pediatric parenteral nutrition utilization
Higher premature birth rates are increasing the number of neonates born with underdeveloped gastrointestinal function and limited nutrient reserves, creating immediate dependence on intravenous nutrition in neonatal intensive care units. This is contributing to market size growth in the parenteral nutrition market because preterm infants often require precisely balanced formulations of proteins, lipids, glucose, electrolytes, vitamins, and trace elements during the most critical stages of early development. Demand is shaped not just by admission volumes but by the need for specialized pediatric formulations, careful dosing protocols, and close clinical monitoring, which strengthens market development around neonatal and pediatric parenteral nutrition products used in highly controlled care environments.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising cancer prevalence and gastrointestinal disorders increasing demand for intravenous nutritional support | 2.00% | High | North America, Europe | High | Near Term |
| Expanding home parenteral nutrition adoption and advanced multi-chamber formulations improving patient outcomes | 1.70% | Moderate | North America, Asia Pacific | High | Mid Term |
| Increasing premature birth rates accelerating neonatal and pediatric parenteral nutrition utilization | 1.50% | Moderate | North America, Europe | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America held the leading regional share of the parenteral nutrition market in 2025, accounting for 43.99% share, backed by its well-established hospital and infusion care infrastructure, broad access to clinical nutrition therapies, and routine use of specialized nutritional support in acute and long-term care settings. The region’s leadership is reinforced by the practical integration of parenteral nutrition into intensive care, oncology, neonatal, and gastrointestinal treatment pathways, where standardized prescribing practices, trained clinical teams, and reliable sterile compounding capabilities sustain consistent product demand.
Asia Pacific is projected to expand at a 6.89% CAGR over the forecast period, with growth in the parenteral nutrition market being impelled by improving hospital capacity, rising access to critical care, and wider adoption of advanced clinical nutrition in large patient populations. Demand is accelerating as healthcare systems across the region strengthen treatment capabilities for premature infants, surgical patients, and individuals with severe malnutrition or gastrointestinal disorders, while expanding awareness of nutrition support in hospital practice is translating into more frequent use of parenteral formulations in day-to-day care delivery.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Clinical Quality FocusGermany prioritizes high-quality parenteral nutrition products supported by established hospital pharmacy practices and strict quality requirements. Demand in Germany increasingly centers on customized formulations, dependable supply chains, and efficient hospital procurement strategies.
France 🇫🇷
Specialized Clinical SupplyFrance focuses on clinically standardized parenteral nutrition supported by centralized healthcare procurement and specialized hospital care. Healthcare institutions across France value consistent product availability, regulatory compliance, and tailored nutrition support for complex treatment pathways.
Italy 🇮🇹
Compounding Care ExcellenceItaly maintains strong demand for parenteral nutrition through hospital pharmacies and clinical nutrition services serving acute and chronic care patients. The Italian market emphasizes customized compounding capabilities, product quality, and dependable supply for healthcare facilities.
Japan 🇯🇵
Aging Care NutritionJapan's parenteral nutrition market is shaped by the clinical needs of an aging population requiring long-term nutritional support. Healthcare providers in Japan emphasize safe formulations, infection control, and efficient hospital-based nutrition management for vulnerable patients.
South Korea 🇰🇷
Advanced Hospital IntegrationSouth Korea integrates parenteral nutrition products within technologically advanced hospital systems focused on specialized patient care. The market in South Korea supports demand for high-quality sterile preparations, improved clinical efficiency, and expanding use in intensive care settings.
United States 🇺🇸
Hospital Nutrition InnovationThe U.S. parenteral nutrition market emphasizes advanced clinical nutrition formulations, home infusion expansion, and resilient sterile manufacturing capacity. Healthcare providers in the U.S. continue to prioritize product reliability, safety standards, and specialized nutrition solutions for complex patient populations.
Segment Leadership and Growth Trends
Parenteral Nutrition Market Share (%), Stage Type, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportThe Adult segment held the dominant position in the parenteral nutrition market in 2025, accounting for an 82.75% share. Its leadership is underpinned by the broad and routine use of parenteral nutrition in adult hospital care, where patients undergoing major surgery, critical illness, gastrointestinal complications, or cancer treatment often require dependable nutritional support when oral or enteral feeding is not feasible. This larger clinical base keeps Adult parenteral nutrition central to standard inpatient treatment pathways and supports its dominant share in the market.
Pediatrics is emerging as the fastest-growing segment in the parenteral nutrition market as neonatal and pediatric care increasingly depends on specialized nutrition support for infants and children with low birth weight, congenital disorders, prematurity, or intestinal dysfunction. Growth is being reinforced by the need for carefully tailored formulations and closer nutritional management in younger patients, making pediatric parenteral nutrition more critical in settings where precise intervention can strongly affect recovery and development. This higher level of clinical specialization is helping Pediatrics gain momentum faster than adult alternatives.
Sales Channel Segment Analysis: Institutional (Largest Segment) vs Online (Fastest-Growing Segment)
In 2025, Institutional accounted for a 50.99% share of the parenteral nutrition market, making it the leading sales channel. This position reflects the fact that parenteral nutrition is primarily administered in hospitals, specialty clinics, and other supervised care settings where prescribing, compounding, storage, and patient monitoring are tightly controlled. Because these products are closely tied to clinical protocols and professional oversight, institutional procurement remains the main route through which demand is concentrated, sustaining the segment’s market share.
Online is the fastest-growing sales channel in the parenteral nutrition market, reinforced through the gradual expansion of digital procurement models for medical nutrition products and related supplies. Its momentum comes from improved purchasing convenience, broader product visibility, and more efficient access for repeat ordering, particularly where home-based care and outpatient nutrition management are becoming more organized. Compared with conventional channels, online platforms are experiencing stronger uptake because they simplify access and purchasing workflows without changing the clinically prescribed nature of parenteral nutrition use.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Stage Type | Adult, Pediatrics | Adult | Pediatrics |
| Sales Channel | Online, Retail, Institutional | Institutional | Online |
| Nutrient Type | Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, Vitamins & Minerals | Single Dose Amino Acid Solution | Parenteral Lipid Emulsion |
| Indication | Alzheimer's, Nutrition Deficiency, Cancer, Diabetes, Chronic Kidney Diseases, Orphan Diseases, Dysphagia, Pain Management, Malabsorption/GI Disorder/Diarrhea, Others | Cancer | Dysphagia |
Competitive Landscape and Market Positioning
1. Baxter International Inc. (United States)
2. Fresenius Kabi AG (Germany)
3. B. Braun SE (B. Braun Melsungen AG) (Germany)
4. Otsuka Pharmaceutical Factory Inc. (Japan)
5. Grifols S.A. (Spain)
6. Pfizer Inc. (United States)
7. ICU Medical Inc. (United States)
8. Sichuan Kelun Pharmaceutical Co. Ltd. (China)
9. JW Pharmaceutical Corporation (South Korea)
10. CSL Limited (Australia)
The parenteral nutrition market is witnessing continuous evolution driven by innovation in specialized nutritional formulations. Development efforts are increasingly focused on addressing complex patient-specific needs through improved composition science. Strategic consolidation activities are reshaping operational capabilities and enabling broader reach across care settings. Expansion into new therapeutic nutrition segments is further strengthening market adaptability and responsiveness.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| H.I.G. Capital | Jun-25 | H.I.G. Capital finalized the acquisition of ITH Group, a prominent provider of aseptic pharmaceutical compounding services. The transaction directly strengthens operational compounding capabilities required for customized, sterile parenteral nutrition formulations across the healthcare sector. |
| Orbicular, Gland Pharma, Apotex | Apr-26 | Orbicular, Gland Pharma, and Apotex secured U.S. FDA regulatory approval for a generic version of INFUVITE ADULT injectable, a critical clinical parenteral nutrition therapy. The Competitive Generic Therapy designation awards six months of domestic market exclusivity, shifting competitive dynamics. |
| Pharmbio Korea | Dec-25 | Pharmbio Korea achieved domestic regulatory clearance for Neonatrium Injection, establishing South Korea’s first locally developed sodium acetate injectable product. The formulation serves as an essential electrolyte constituent used within custom parenteral nutrition preparations. |
| Fresenius Kabi Korea | Apr-24 | Fresenius Kabi Korea introduced Ntense Injection and Ntense EF Injection, two specialized high-amino-acid intravenous clinical formulations. The multi-chamber products are commercialized to deliver targeted calories, amino acids, essential fatty acids, and omega-3s for pediatric and adult patient populations requiring parenteral support. |
| Rela Hospital | Mar-25 | Rela Hospital launched the first dedicated Centre for Intestinal Rehabilitation and Nutrition Support in Mumbai, India. The new facility expands regional healthcare infrastructure specifically optimized for the management and distribution of long-term parenteral nutrition therapies. |
| American Regent | Mar-22 | American Regent introduced its Selenious Acid Injection, USP, in a single-dose vial format. The trace element formula is commercialized for adult, pediatric, and neonatal patients under 7 kilograms, directly addressing nutritional deficits in clinical cohorts restricted from receiving oral or enteral nutrition. |
| VAV Lipids | Apr-24 | VAV Lipids expanded manufacturing and operational capacity to meet global demand for specialized pharmaceutical-grade egg yolk lecithin. The lipid component functions as a critical raw ingredient required to manufacture commercial lipid emulsions within advanced parenteral nutrition formulations. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Parenteral Nutrition Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
Parenteral Nutrition Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchHow large is the parenteral nutrition market?
What is the expected industry size of parenteral nutrition by 2035?
How is rising incidence of cancer and gastrointestinal disorders driving demand in the parenteral nutrition market?
How is the shift toward home-based care influencing parenteral nutrition adoption?
Why is the adult segment the largest in the parenteral nutrition market?
Why is the online sales channel the fastest-growing segment in the parenteral nutrition market?
Why is North America the leading region in the parenteral nutrition market?
What is driving parenteral nutrition market growth in Asia Pacific?
Who holds a significant market share in the parenteral nutrition landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization